GSE179693 GSE179694 panobinostat 4 v 2 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE179693_GSE179694_panobinostat_4_v_2_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE179693_GSE179694_panobinostat_4_v_2_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE179693_GSE179694_panobinostat_4_v_2_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE179693_GSE179694_panobinostat_4_v_2_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

growth arrest specific 5

Gene

small nucleolar RNA host gene 29

Gene

small nucleolar RNA host gene 16

Gene

CENPB DNA-binding domains containing 2, pseudogene

Gene

MIR34A host gene

Gene

HLA complex group 18

Gene

activator of HSP90 ATPase homolog 2, pseudogene

Gene

PRR34 antisense RNA 1

Gene

WASP family homolog 5, pseudogene

Gene

CTBP1 divergent transcript

  • Gene

    growth arrest specific 5


  • Gene

    small nucleolar RNA host gene 29


  • Gene

    small nucleolar RNA host gene 16


  • Gene

    CENPB DNA-binding domains containing 2, pseudogene



  • Gene

    HLA complex group 18


  • Gene

    activator of HSP90 ATPase homolog 2, pseudogene


  • Gene

    PRR34 antisense RNA 1


  • Gene

    WASP family homolog 5, pseudogene


  • Gene

    CTBP1 divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.